PRQR CIK: 1612940

ProQR Therapeutics N.V.

  • Netherlands
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−26.0
FY22:
−68.5
FY23:
21.5
FY24:
−36.4
FY25:
−52.8
Change from FY21 to FY25
millions EUR
FY21:
−0.43
FY22:
−0.70
FY23:
4.28
FY24:
−4.07
FY25:
−1.02
Change from FY21 to FY25
millions EUR
FY21:
137
FY22:
−30.9
FY23:
−2.28
FY24:
70.3
FY25:
−1.84
millions EUR
FY21:
110
FY22:
−100
FY23:
23.6
FY24:
29.8
FY25:
−55.6
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−26.5
FY22:
−69.2
FY23:
20.2
FY24:
−37.8
FY25:
−53.8

All amounts in millions EUR Data source:SEC EDGAR